Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Normative Hand Grip Strength Values in Swedish Male and Female Ice Hockey Players Across Competitive Levels

22 de maio de 2026 atualizado por: Daniel Muder, Dalarna County Council, Sweden

This study measures hand grip strength in male and female ice hockey players across different Swedish leagues to create reference (normative) values for adult players.

Hand grip strength is a simple test of how strongly a person can squeeze with their hand. Although it seems basic, it reflects overall upper-body strength and is widely used in both sports science and healthcare.

In this project, players from different levels of ice hockey (including professional men's and women's leagues, junior players, and recreational players if available) will have their grip strength measured using a standardized hand dynamometer. Measurements will be taken in a consistent way across all participating clubs.

The main goal is to build a reference database showing what "normal" grip strength looks like in ice hockey players depending on sex, league level, and playing position. This can help coaches, medical staff, and researchers better understand strength profiles in hockey athletes, support training and rehabilitation decisions, and provide benchmarks for future studies.

No treatment or intervention is given as part of the study.

Visão geral do estudo

Status

Ainda não está recrutando

Descrição detalhada

This is a cross-sectional, descriptive, multi-league study designed to establish normative values for maximal isometric hand grip strength in adult Swedish ice hockey players.

Hand grip strength will be used as a standardized, low-cost proxy measure of upper-body muscular strength and general functional capacity. Although grip strength is widely used in clinical and sports science settings and has demonstrated good reliability when measured using standardized protocols, there is currently a lack of comprehensive normative data for adult ice hockey players. Existing literature is largely limited to youth cohorts or general athletic "combine"-type populations, with insufficient stratification for adult competitive ice hockey across sexes, league levels, and playing positions.

This study will include male and female players from multiple competitive levels in Swedish ice hockey, including professional leagues (SHL and SDHL), second-tier leagues (HockeyAllsvenskan and Women's Allsvenskan where feasible), junior elite levels (U18/U20), and potentially recreational adult players. Participants will be recruited through participating clubs during the pre-season or early competitive season period.

Grip strength will be measured using a standardized hand dynamometer according to a unified protocol aligned with established clinical measurement guidelines (including standardized positioning, device calibration, and repeated trials per hand). Both dominant and non-dominant hand grip strength will be recorded, and mean values will be used for analysis. To reduce inter-tester variability, participating sites will be instructed to follow a harmonized measurement protocol.

In addition to grip strength, basic demographic and anthropometric data will be collected, including age, sex, playing position (forward/defense), playing experience, height, and body mass. Where available, supplementary body composition data from club testing routines may also be included to allow exploratory analyses of strength relative to body size.

The primary purpose of the study is descriptive: to generate normative reference values (including percentiles) for grip strength in adult ice hockey players, stratified by sex, league level, and playing position. Secondary analyses will explore associations between grip strength and anthropometric and demographic variables.

This study does not include any intervention or experimental treatment. All measurements are non-invasive and performed during routine testing environments within clubs. The results are intended to support strength and conditioning practice, clinical assessment in sports medicine, and future research on performance, injury risk, and rehabilitation in ice hockey.

Tipo de estudo

Observacional

Inscrição (Estimado)

800

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Método de amostragem

Amostra Não Probabilística

População do estudo

Adult male and female ice hockey players recruited from Swedish ice hockey clubs across multiple competitive levels, including professional (SHL and SDHL), second-tier (HockeyAllsvenskan and Women's Allsvenskan where available), junior elite (U18/U20), and selected recreational teams. Participants are drawn from active club rosters during the pre-season or early competitive season period. Recruitment is conducted in collaboration with participating clubs and their medical or strength and conditioning staff. The population represents a broad sample of Swedish ice hockey players across sex, age, and competitive level.

Descrição

Inclusion Criteria:

  • Adult male or female ice hockey players.
  • Registered and actively participating in a Swedish ice hockey club during the current season.
  • Participation in one of the included competitive levels: professional, semi-professional, junior elite, or recreational leagues in Sweden.
  • Able to perform maximal hand grip strength testing. Provides written informed consent.

Exclusion Criteria:

  • Current acute injury of the upper extremity (hand, wrist, forearm, or elbow) that prevents safe or valid grip strength testing.
  • Any medical condition that contraindicates maximal effort testing, as determined by team medical staff or study personnel.
  • Refusal or inability to provide informed consent.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

Coortes e Intervenções

Grupo / Coorte
Ice Hockey Players
Adult male and female ice hockey players from multiple competitive levels in Sweden, including professional, semi-professional, junior elite, and recreational players. Participants undergo a single standardized measurement of hand grip strength.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Maximal Hand Grip Strength
Prazo: Baseline.
Maximal isometric hand grip strength measured in kilograms using a standardized hand dynamometer in adult male and female ice hockey players. Measurements will be performed for both dominant and non-dominant hands using a standardized protocol, and mean maximal value will be used for analysis.
Baseline.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Anthropometric Characteristics
Prazo: Baseline.
Height (cm), body mass (kg), and body composition (if available) of adult male and female ice hockey players.
Baseline.
Demographic and Playing Characteristics
Prazo: Baseline.
Age, sex, playing position (forward/defense), league level, dominant hand, and years of playing experience in ice hockey.
Baseline.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Daniel Muder, MD, PhD, Centre for Clinical Research Dalarna, Uppsala University, Sweden

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de setembro de 2026

Conclusão Primária (Estimado)

31 de dezembro de 2026

Conclusão do estudo (Estimado)

31 de dezembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

23 de abril de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

30 de abril de 2026

Primeira postagem (Real)

5 de maio de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

27 de maio de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

22 de maio de 2026

Última verificação

1 de maio de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 2026-02210-01B

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

Any data shared with colleagues or collaborating researchers will be fully anonymized or pseudonymized to protect participant privacy in accordance with GDPR regulations. Data transfers will occur under strict confidentiality agreements, and all parties will adhere to applicable data protection laws to ensure the security and privacy of personal information. We will act in accordance with the ethical approval granted by the Swedish Ethical Review Authority (EPM) and comply with all relevant local policies regarding data protection.

Prazo de Compartilhamento de IPD

From the publication of the protocol and for 10 years thereafter.

Critérios de acesso de compartilhamento IPD

Access to individual participant data is typically restricted to authorized researchers involved in the study or approved collaborators under strict confidentiality and data protection agreements.

Tipo de informação de suporte de compartilhamento de IPD

  • PROTOCOLO DE ESTUDO
  • SEIVA
  • CIF

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever